Market Closed -
Bombay S.E.
03:54:53 09/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
1,691
INR
|
-1.43%
|
|
-1.17%
|
-12.07%
|
Fiscal Period: März |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,05,432
|
5,37,705
|
2,08,882
|
2,78,855
|
-
|
-
|
Enterprise Value (EV)
1 |
3,75,414
|
5,06,809
|
1,71,208
|
2,51,359
|
2,47,305
|
2,42,006
|
P/E ratio
|
39.3
x
|
44.4
x
|
26.7
x
|
32.8
x
|
25.3
x
|
22.8
x
|
Yield
|
-
|
-
|
-
|
0.14%
|
0.25%
|
0.21%
|
Capitalization / Revenue
|
11.7
x
|
12.2
x
|
5.76
x
|
4.94
x
|
4.41
x
|
3.94
x
|
EV / Revenue
|
10.8
x
|
11.5
x
|
4.72
x
|
4.45
x
|
3.91
x
|
3.42
x
|
EV / EBITDA
|
28.8
x
|
33.6
x
|
16.7
x
|
18.6
x
|
15.3
x
|
13.3
x
|
EV / FCF
|
99.8
x
|
181
x
|
120
x
|
-22.2
x
|
43.6
x
|
27.1
x
|
FCF Yield
|
1%
|
0.55%
|
0.84%
|
-4.5%
|
2.29%
|
3.68%
|
Price to Book
|
6.51
x
|
7.48
x
|
2.62
x
|
3.16
x
|
2.8
x
|
2.53
x
|
Nbr of stocks (in thousands)
|
1,63,593
|
1,64,303
|
1,64,701
|
1,64,711
|
-
|
-
|
Reference price
2 |
2,478
|
3,273
|
1,268
|
1,693
|
1,693
|
1,693
|
Announcement Date
|
17/05/21
|
19/05/22
|
18/05/23
|
-
|
-
|
-
|
Fiscal Period: März |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
26,332
|
34,629
|
44,007
|
36,246
|
56,490
|
63,200
|
70,724
|
EBITDA
1 |
-
|
13,022
|
15,102
|
10,248
|
13,492
|
16,200
|
18,263
|
EBIT
1 |
-
|
12,034
|
13,999
|
8,780
|
10,198
|
12,863
|
14,406
|
Operating Margin
|
-
|
34.75%
|
31.81%
|
24.22%
|
18.05%
|
20.35%
|
20.37%
|
Earnings before Tax (EBT)
1 |
-
|
13,348
|
16,186
|
10,546
|
11,692
|
14,527
|
16,171
|
Net income
1 |
-
|
9,970
|
12,117
|
7,810
|
8,480
|
11,024
|
12,226
|
Net margin
|
-
|
28.79%
|
27.53%
|
21.55%
|
15.01%
|
17.44%
|
17.29%
|
EPS
2 |
-
|
62.99
|
73.64
|
47.43
|
51.66
|
66.98
|
74.32
|
Free Cash Flow
1 |
-
|
3,762
|
2,800
|
1,430
|
-11,309
|
5,667
|
8,914
|
FCF margin
|
-
|
10.86%
|
6.36%
|
3.95%
|
-20.02%
|
8.97%
|
12.6%
|
FCF Conversion (EBITDA)
|
-
|
28.89%
|
18.54%
|
13.96%
|
-
|
34.98%
|
48.81%
|
FCF Conversion (Net income)
|
-
|
37.73%
|
23.11%
|
18.31%
|
-
|
51.41%
|
72.91%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
2.333
|
4.250
|
3.500
|
Announcement Date
|
10/07/20
|
17/05/21
|
19/05/22
|
18/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
8,877
|
11,539
|
10,805
|
10,633
|
11,030
|
8,569
|
10,444
|
9,383
|
7,850
|
12,087
|
13,439
|
14,508
|
15,710
|
15,977
|
EBITDA
1 |
3,277
|
4,363
|
3,766
|
3,489
|
3,484
|
2,699
|
2,969
|
2,896
|
1,684
|
2,982
|
3,128
|
3,600
|
3,708
|
-
|
EBIT
1 |
3,028
|
4,110
|
3,505
|
3,211
|
3,173
|
2,350
|
2,602
|
2,520
|
1,309
|
2,286
|
2,299
|
2,769
|
2,734
|
3,116
|
Operating Margin
|
34.1%
|
35.62%
|
32.44%
|
30.2%
|
28.77%
|
27.43%
|
24.91%
|
26.85%
|
16.67%
|
18.92%
|
17.11%
|
19.09%
|
17.4%
|
19.5%
|
Earnings before Tax (EBT)
1 |
3,489
|
4,718
|
4,007
|
3,656
|
3,805
|
3,085
|
3,241
|
3,108
|
1,112
|
2,613
|
2,828
|
3,354
|
3,302
|
-
|
Net income
1 |
2,604
|
3,507
|
3,021
|
2,730
|
2,859
|
2,292
|
2,412
|
2,319
|
786.8
|
1,941
|
2,161
|
2,332
|
2,336
|
-
|
Net margin
|
29.33%
|
30.39%
|
27.96%
|
25.68%
|
25.92%
|
26.74%
|
23.1%
|
24.72%
|
10.02%
|
16.06%
|
16.08%
|
16.07%
|
14.87%
|
-
|
EPS
2 |
-
|
21.37
|
18.37
|
16.62
|
17.36
|
13.92
|
14.65
|
14.08
|
4.780
|
11.78
|
12.70
|
13.60
|
14.23
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
17/05/21
|
21/07/21
|
22/10/21
|
21/01/22
|
19/05/22
|
20/07/22
|
26/10/22
|
23/01/23
|
18/05/23
|
07/08/23
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
30,018
|
30,896
|
37,674
|
27,496
|
31,550
|
36,849
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
3,762
|
2,800
|
1,430
|
-11,309
|
5,667
|
8,914
|
ROE (net income / shareholders' equity)
|
-
|
20.9%
|
18.6%
|
10.3%
|
9.93%
|
11.3%
|
11.6%
|
ROA (Net income/ Total Assets)
|
-
|
18.8%
|
16.9%
|
9.4%
|
8.8%
|
10.9%
|
11.4%
|
Assets
1 |
-
|
52,911
|
71,651
|
83,056
|
96,366
|
1,01,224
|
1,07,246
|
Book Value Per Share
2 |
-
|
381.0
|
438.0
|
483.0
|
535.0
|
605.0
|
669.0
|
Cash Flow per Share
2 |
-
|
-
|
-
|
22.10
|
38.40
|
61.80
|
-
|
Capex
1 |
-
|
2,288
|
5,113
|
2,209
|
10,447
|
4,248
|
3,289
|
Capex / Sales
|
-
|
6.61%
|
11.62%
|
6.1%
|
18.49%
|
6.72%
|
4.65%
|
Announcement Date
|
10/07/20
|
17/05/21
|
19/05/22
|
18/05/23
|
-
|
-
|
-
|
Last Close Price
1,693
INR Average target price
1,845
INR Spread / Average Target +8.99% Consensus |
1st Jan change
|
Capi.
|
---|
| +32.36% | 698B | | +26.51% | 568B | | -4.40% | 358B | | +19.46% | 328B | | +3.50% | 283B | | +16.34% | 238B | | +6.68% | 203B | | -9.08% | 198B | | +8.62% | 165B |
Other Pharmaceuticals
|